Edition:
United Kingdom

People: Regeneron Pharmaceuticals Inc (REGN.OQ)

REGN.OQ on NASDAQ Stock Exchange Global Select Market

331.97USD
22 Jun 2018
Change (% chg)

$2.93 (+0.89%)
Prev Close
$329.04
Open
$330.05
Day's High
$334.52
Day's Low
$326.90
Volume
288,282
Avg. Vol
323,673
52-wk High
$543.50
52-wk Low
$281.89

Powchik, Peter 

Dr. Peter Powchik, M.D., is Senior Vice President - Clinical Development of the Company. Dr. Powchik was employed at several pharmaceutical companies, serving as Senior Vice President and Chief Medical Officer of Chugai Pharma USA, a position he held from May 2005 until October 2006. From April 2001 until May 2005, he held various senior clinical development positions at Novartis Pharmaceuticals Corporation, most recently as Vice President, US Clinical Development and Medical Affairs. Dr. Powchik held various clinical development positions with Sepracor Inc. and Pfizer Inc. from October 1996 to April 2001. Dr. Powchik received his M.D. from New York University School of Medicine.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

P. Roy Vagelos

13,240,600

Leonard Schleifer

28,337,500

Robert Landry

5,164,730

Daniel Van Plew

2,188,990

Neil Stahl

10,985,400

Joseph LaRosa

--
As Of  31 Dec 2016